-
SHUWEN HU
Counsel·Shanghai
PROFILE REPRESENTATIVE MATTERS AND CASES OTHER INFORMATION Further Reading
MS. HU SPECIALIZES IN CAPITAL MARKETS, M&A, PRIVATE EQUITY AND GENERAL CORPORATE.
Education
Shanghai University, School of Law, LL.B.
Fudan University, School of Law, LL.M.
Professional Qualification
Admitted to practice in the PRC
Professional Background
Ms. Hu joined the Shanghai office of Fangda Partners in 2018.
PROFILE
REPRESENTATIVE MATTERS AND CASES
- Represented Shanghai Fudan Zhangjiang Bio-Pharmaceutical in its A-share IPO on the STAR Market
- Represented Ant Group in its A-share and H-share dual listing
- Represented Focusight (Jiangsu) Technology in its A-share IPO on the STAR Market
- Acted as underwriter’s counsel in Shanghai New Centurion Network Information Technology’s A-share IPO
- Acted as underwriter’s counsel in Hangzhou Raycloud Technology’s A-share IPO on the STAR Market
- Represented China Shipbuilding Industry Group Power in its major asset restructuring
- Represented China United Travel in its major asset restructuring
- Represented Shanghai SynTheAll Pharmaceutical in its major asset restructuring
- Acted as the independent financial advisor’s counsel in the major asset restructuring of Sinopharm National Medicine
- Acted as the investor’s counsel in the major asset restructuring of Longshine Technology Group
- Represented Guangdong Ganhua Science & Industry Co. in its acquisition of a defense industry company
- Represented Black Peony (Group) in its acquisition of an infrastructure company that builds roads and bridges
- Represented Shanghai Kinlita Chemical in the transfer of its controlling right
- Represented Shenyang Blue Silver Industry Automatic Equipment and its controlling shareholder in their domestic financing
- Represented Shanghai Junshi Biosciences in its domestic financing
- Represented Fu Jian Anjoy Foods in the issuance of convertible bonds
- Represented Black Peony (Group) in its domestic financing
- Represented Zhejiang Cainiao Supply Chain Management in its investment in YTO Express Group’s convertible bonds
- Represented Alibaba in its investment in Beijing Timeloit Technology
- Represented Boyu Capital in its investment in Yimi Dida Supply Chain Group
- Represented Shanghai Fudan Zhangjiang Bio-Pharmaceutical in its investment in Shanghai WD Pharmaceutical Technology
- Represented Puyi (Shanghai) Bio-Tech in its Series B financing
- Represented Shanghai Fudan Zhangjiang Bio-Pharmaceutical in it’s a-share equity inventive plan and repurchase of H shares
